Retinopathy of prematurity in practice. I: Screening for threshold disease

Eye

Volumn 17, Issue 2, 2003, Pages 183-188

  Brennan, R ^a   Gnanaraj, L ^a   Cottrell, D G ^a  

^a ROYAL VICTORIA INFIRMARY   (United Kingdom)

Author keywords

Birth weight; Gestational age; Retinopathy of prematurity (ROP)

Indexed keywords

ARTICLE; BIRTH WEIGHT; CONTROLLED STUDY; DATA BASE; GESTATIONAL AGE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MEDICAL PRACTICE; MEDICAL SPECIALIST; NEWBORN; OPHTHALMOSCOPY; PRACTICE GUIDELINE; PROSPECTIVE STUDY; RETROLENTAL FIBROPLASIA; SCREENING TEST; TREATMENT OUTCOME; WORKLOAD;

EID: 0037356145     PISSN: 0950222X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.eye.6700296     Document Type: Article

References (27)

1. Multicentre Trial of Cryotherapy for Retinopathy of Prematurity. One-year outcome-structure and function. Arch Ophthalmol 1990; 108: 1408-1416.
2. Fledelius HC, Kjer B, Rosenberg T. Retinopathy of prematurity in a Copenhagen high-risk sample. 1997-98. Acta Ophthalmol Scand 2000; 78: 362-365.
3. Holmström G, El Azazi M, Jacobson L, Lennerstrand G. A population based, prospective study of the development of ROP in prematurely born children in the Stockholm area of Sweden. Br J Ophthalmol 1993; 77: 417-423.
4. Goble RR, Jones HS, Fielder AR. Are we screening too many babies for retinopathy of prematurity? Eye 1997; 11: 509-514.
5. Pennefather PM, Clarke MP, Strong NP, Cottrell DG, Fritz S, Tin W. Ocular outcome in children born before 32 weeks gestation. Eye 1995; 9(Suppl): 26-36.
6. Gnanaraj L, Brennan R, Cottrell DG. Retinopathy of prematurity in practice. II: long term results following treatment for threshold disease. Eye 2003; 17: 187-191.
7. Committee for the Classification of Retinopathy of Prematurity. An international classification of retinopathy of prematurity. Br J Ophthalmol 1984; 68: 690-697.
8. Anon. College news: ROP screening duty. Q Bull Coll Ophthalmol 1990; Autumn: 6.
9. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Multicenter Trial of Cryotherapy for Retinopathy of Prematurity; preliminary results. Arch Ophthalmol 1988; 106: 471-479.
10. Fielder AR, Shaw DE, Robinson J, Ng YK. Natural history of retinopathy of prematurity: a prospective study. Eye 1992; 6: 233-242.
11. Vyas J, Field D, Draper ES et al. Severe retinopathy of prematurity and its association with different rates of survival in infants of less than 1251 g birth weight. Arch Dis Child Fetal Neonatal Ed 2000; 82: F145-F149.
12. Bagdoniene R, Surtautiene R. Threshold retinopathy of prematurity in Lithuania. In: Reibaldi A, Di Pietro M, Scuderi A, Malerba E (eds). Progress in Retinopathy of Prematurity. Kugler Publications: Amsterdam/New York, 1997, pp 31-36.
13. Ziakas NG, Cottrell DG, Milligan DWA, Pennefather PM, Bamashmus MA, Clarke MR Regionalisation of retinopathy of prematurity (ROP) screening improves compliance with guidelines: an audit of ROP screening in the Northern Region of England. Br J Ophthalmol 2001; 85: 807-810.
14. Quinn GE, Johnson L, Abbasi S. Onset of retinopathy of prematurity as related to postnatal and postconceptional age. Br J Ophthalmol 1992; 76: 284-288.
15. Schalij-Delfos NE, Zijlmans BLM, Wittebol-Post D, Tan KEWP, Cats BP. Screening for retinopathy of prematurity: do former guidelines still apply? J Pediatr Ophthalmol Strabismus 1996; 33: 35-38.
16. Fledelius HC, Dahl H. Retinopathy of prematurity, a decrease in frequency and severity Trends over 16 years in a Danish county. Acta Ophthalmol Scand 2000; 78: 359-361.
17. A joint statement of the American Academy of Pediatrics, the American Association for Pediatric Ophthalmology and Strabismus, and the American Academy of Ophthalmology. Screening examination of premature infants for retinopathy of prematurity. Ophthalmology 1997, 104: 888-889.
18. Flynn JT. Optimal timing of examination for acute retrolental fibroplasia. Ophthalmology 1981; 88: 667-668.
19. Wilkinson AR, Clark D, Fielder A et al. Retinopathy of prematurity: guidelines for screening and treatment. The report of a joint working party of the Royal College of Ophthalmologists and the British Association of Perinatal Medicine. Early Hum Dev 1996; 46: 239-258.
20. Supplemental Therapeutic Oxygen for Prethreshold Retinopathy of Prematurity (STOP-ROP), a randomized, controlled trial. I: primary outcomes. Pediatrics 2000; 105(2): 295-310.
21. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Multicenter Trial of Cryotherapy for Retinopathy of Prematurity Ophthalmological outcomes at 10 years. Arch Ophthalmol 2001; 119: 1110-1118.
22. Pollock W, Inglesby DV, Cottrell DG. Retinopathy of prematurity: guidelines for screening and treatment (letter; comment). Eye 1998; 12: 1035.
23. Sauders RA, Donahue ML, Berland JE, Roberts EL, Von Powers B, Rust PF. Non-ophthalmologist screening for retinopathy of prematurity. Br J Ophthalmol 2000; 84: 130-134.
24. Good WV, Hardy RJ. The Multicenter Study of Early Treatment for Retinopathy of Prematurity (ETROP). Ophthalmology 2001; 108(6): 1013-1014.
25. Laws DE, Morton C, Weindling, Clark D. Systemic effects of screening for retinopathy of prematurity. Br J Ophthalmol 1996; 80: 425-428.
26. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Multicenter Trial of Cryotherapy for Retinopathy of Prematurity: Snellen visual acuity and structural outcome at 5 1/2 years after randomisation. Arch Ophthalmol 1996; 114: 417-424.
27. Javitt J, Dei Cas R, Chiang YP. Cost-effectiveness of screening and cryotherapy for threshold retinopathy of prematurity. Pediatrics 1993; 91(5): 859-866.